Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
51 Cards in this Set
- Front
- Back
- 3rd side (hint)
Chemical used to diagnose, treat or prevent disease
|
Drug
|
|
|
Study of drugs and their interaction with the body
|
Pharmacology
|
|
|
Name suggested by the manufacturer
|
Generic Name
|
|
|
Manufacturer given to increase brand loyality
|
Brand name
|
|
|
How drug is absorbed, distributed and elimnated
|
Pharmacokinetics
|
|
|
Adverse reactions
Drugs undesired effects |
Side Effects
|
|
|
HOw drug is given
|
Routes of administration
|
|
|
Conditions make it inappropriate to give the drug
|
Contraindications
|
|
|
amount of drug that should be given
|
Dosage
|
|
|
Federal
State Individual Agencies |
Legal
|
|
|
High Abuse, no accepted medical indications
|
schedule 1
|
LSD Heroin
|
|
High abuse, accepted medical indications
|
Schedule 2
|
Morphine, cocaine
|
|
Less abuse, psychological dependency
|
Schedule 3
|
Vicodin, tylenol, codeine
|
|
Low abuse, limited psychological dependence
|
Schedule 4
|
Valium, phenobarbital
|
|
Lowest abuse, very limited psychological dependence
|
Schedule 5
|
cough medicine w codiene
|
|
6 rights of medication Administration
|
right person
right drug right dose right time right route right documentation |
|
|
Identify person by name
do not confuse multiple patiens |
Right person
|
|
|
Repeat physicians orders back
Withdraw right medication |
Right Drug
|
|
|
Pull medication out of box
draw up medication before adminster to patient double check with partner |
right drug
|
|
|
Medication given
Dose given Time given Effects seen |
Right documentation
|
|
|
no risk to fetus in 1st or later trimesters
|
category A
|
|
|
potential risk in animal studies, but not in pregnant women
|
Category B
|
|
|
No studies or benefits may outweigh the risks
|
Category c
|
|
|
Risk exist, but benefits may outweigh those risks
|
Categroy D
|
|
|
Fetal risk demonstrated. Risk far outweigh benefit
|
Category X
|
|
|
Metabolism and extracellular fluids may be increased(higher metabolism)
|
pediatric patients
|
|
|
Broselow tape
|
always use pediatric tools
|
|
|
Pharmacology
2 divisions |
pharmacokinetics
Pharmacodynamics |
|
|
How drug is transported in and out of the body
absorbtion distribution biotransformation elimination |
pharmacokinetics
|
|
|
Effects of the drug when they reach their target tissues
|
Pharmacodynamics
|
|
|
requires energy to move a substance
|
active transport
|
|
|
requires a carrier protien to transport large molecules
|
Facilitated Diffusion
|
|
|
Movement of substance are of higher concentration to area of lower concentration
|
diffusion
|
|
|
fluid like water area are of higher concentration to area of lower concentration
|
osmosis
|
|
|
movement from high pressure to a lower pressure
|
Filtration
|
|
|
How the drug finds its way to desired tissue
|
absorption
|
|
|
must get into blood stream first
|
absorption
|
|
|
amount of drug that is still active after it reaches its target tissue
|
Bioavailibilty
|
|
|
HOw drug is distributed throughout the body
|
distribution
|
|
|
distributed through the circulatory system
|
distribution
|
|
|
dependent on binding in the blood stream
albumin in the blood big blood protein |
distribution
|
|
|
tight junction between capillary and endothelial cells prevent this?
|
prevent distribution
|
|
|
Breakdown of drugs
|
Biotransformation
|
|
|
transform drug into a more or less active metabolite
|
Biotransformation
|
|
|
make drug more water or less lipid soluble to facilitate elimination
|
Biotransormation
|
|
|
First pass through the liver may partially or completely inactivate many drugs
|
"first-pass effect"
|
|
|
extreted through urine, feces or expiration
|
Elimination
|
|
|
medication delivered through GI tract
|
enteral
|
|
|
medications delivered any area outside the Gi tract
|
Parenteral
|
|
|
Oral
sublingual buccal rectal |
enteral routes
|
|
|
Intravenous (IV)
Endotracheal Intraosseous (IO) Umbilical Intramuscular Subcutaneous Intradermal Inhalation Topical Transderamal Nasal Instillation |
Parenteral routes
|
|